41 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 2, March/April 2017
AFRICA
107
Our study does not support the hypothesis that Vitamin D
levels play a role in the aetiology of POAF. Further prospective,
randomised studies with a larger number of patients are required
to confirm our results.
References
1.
Filardo G, Hamilton C, Hebeler RF Jr, Hamman B, Grayburn P.
New-onset postoperative atrial fibrillation after isolated coronary artery
bypass graft surgery and long-term survival.
Circ Cardiovasc Qual
Outcomes
2009;
2
: 164–169.
2.
Dusso AS, Brown AJ, Slatopolsky E. Vitamin D.
Am J Physiol Renal
Physiol
2005;
289
: 8–28.
3.
MacDonald HM, Mavroeidi A, Fraser WD,
et al
. Sunlight and dietary
contributions to the seasonal Vitamin D status of cohorts of healthy
postmenopausal women living at northerly latitudes: a major cause for
concern?
Osteoporosis Int
2011;
22
: 2461–2472.
4.
Lang RM, Bierig M, Devereux RB,
et al
. Recommendations for cham-
ber quantification.
Eur J Echocardiogr
2006;
7
: 79–108.
5.
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natu-
ral history of atrial fibrillation: incidence, risk factors and prognosis in
the Manito ba Follow-Up Study.
Am J Med
1995;
98
: 476–484.
6.
Banach M, Rysz J, Drozdz JA,
et al
. Risk factors of atrial fibrillation
following coronary artery bypass grafting: A preliminary report.
Circ J
2006;
70
: 438–441.
7.
Li J, Agarwal SK, Alonso A,
et al.
Airflow obstruction, lung func-
tion, and incidence of atrial fibrillation: the Atherosclerosis Risk in
Communities (ARIC) study.
Circulation
2014;
129
: 971–980.
8.
Yamauchi T, Sakata Y, Miura M,
et al.
; CHART-2 investigators.
Prognostic impact of new-onset atrial fibrillation in patients with
chronic heart failure – A report from the CHART-2 study.
Circ J
2015;
80
: 157–167.
9.
Aksakal E, Tanbo
ğ
a IH, Kurt M. Predictors of coronary lesions
complexity in patients with stable coronary artery disease.
Angiology
2013;
64
: 304–309.
10. Wang TJ, Pencina MJ, Booth SL,
et al
. Vitamin D deficiency and risk of
cardiovascular disease.
Circulation
2008;
117
: 503–511.
11. Oz F, Cizgici A. Y, Oflaz H,
et al
. Impact of Vitamin D insufficiency on
the epicardial coronary flow velocity and endothelial function.
Coron
Art Dis
2013;
24
: 392–397.
12. Liew JY, Sasha SR, Ngu PJ,
et al.
Circulating Vitamin D levels are asso-
ciated with the presence and severity of coronary artery disease but not
peripheral arterial disease in patients undergoing coronary angiography.
Nutr Metab Cardiovasc Dis
2015;
25
: 274–279.
13. Gardner DG, Chen S, Glenn DJ. Vitamin D and the heart.
Am J Physiol
Regul Integr Comp Physiol
2013:
305
; 969–977.
14. Chen S, Law CS, Grigsby CL,
et al
. Cardiomyocyte-specific deletion of
the vitamin D receptor gene results in cardiac hypertrophy.
Circulation
2011:
124
; 1838–1847.
15. Tsang TS, Barnes ME, Bailey KR,
et al
. Left atrial volume: important
risk marker of incident atrial fibrillation in 1655 older men and women.
Mayo Clin Proc
2001;
76
: 467–475.
16. Xiang W, Kong J, Chen S,
et al
. Cardiac hypertrophy in vitamin D recep-
tor knockout mice: role of the systemic and cardiac renin–angiotensin
systems.
Am J Physiol Endocrinol Metab
2005:
288
; 125–132.
17. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA.
1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the matu-
ration of fully active immature dendritic cells from monocytes.
Eur J
Endocrinol
2001;
145
: 351–357.
18. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A.
Histological substrate of atrial biopsies in patients with lone atrial fibril-
lation.
Circulation
1997;
96
: 1180–1184.
19. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S.
Evolution of the atrial fibrillation substrate in experimental conges-
tive heart failure: angiotensin-dependent and -independent pathways.
Cardiovasc Res
2003:
2
; 315–325.
20. Demir M, Uyan U, Melek M. The effects of vitamin D deficiency on
atrial fibrillation.
Clin Appl Thromb Hemost
2014:
20
; 98–103.
21. Chen WR, Liu ZY, Shi Y,
et al
. Relation of low vitamin D to nonval-
vular persistent atrial fibrillation in Chinese patients.
Ann Noninvasive
Electrocardiol
2014:
19
; 166–173.
22. Hanafy DA, Chang SL, Lu YY,
et al
. Electromechanical effects
of 1,25-dihydroxyvitamin D with antiatrial fibrillation activities
. J
Cardiovasc Electrophysiol
2014:
3
; 317–323.
23. Forman J.P, Giovannucci E, Holmes MD,
et al
. Plasma 25-hydroxyvi-
tamin D levels and risk of incident hypertension.
Hypertension
2007:
5
; 1063–1069.
24. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG.
25-hydroxyvitamin D levels and risk of ischemic heart disease, myocar-
dial infarction, and early death: population-based study and meta-
analyses of 18 and 17 studies.
Arterioscler Thromb Vasc Biol
2012;
11
:
2794–2800.
25. Poole KE, Loveridge N, Barker PJ,
et al
. Reduced vitamin D in acute
stroke.
Stroke
2006:
1
; 243–245.
26. Rienstra M, Cheng S, Larson MG,
et al
. Vitamin D status is not related
to development of atrial fibrillation in the community.
Am Heart J
2011;
3
: 538–541.
27. Qayyum F, Landex NL, Agner BR, Rasmussen M, Jøns C, Dixen U.
Vitamin D deficiency is unrelated to type of atrial fibrillation and its
complications.
Dan Med J
2012;
59
: 4505.
28. Vitezova A, Cartolano NS, Heeringa J,
et al
. Vitamin D and the risk of
atrial fibrillation. The Rotterdam Study.
PLoS One
2015;
10
: e0125161.